Craig A. Johnson

Insider Reports History

Entity
Individual
Location
C/O Pure Bioscience, 1725 Gillespie Way, El Cajon, CA
Signature
/s/ John Moriarty
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig A. Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Director Stock Option (Right to Buy) 83.7K $149K $1.78 Jan 19, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 65.8K $142K $2.15 Jan 19, 2024 Direct
LA JOLLA PHARMACEUTICAL CO Director Common Stock 0 $6.23 Aug 22, 2022 Direct
LA JOLLA PHARMACEUTICAL CO Director Stock Option (Right to Buy) 0 Aug 22, 2022 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 Jan 23, 2024 Direct

Insider Reports Filed by Craig A. Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 8 $0 4 Jan 23, 2024 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 19, 2024 2 $0 4 Jan 19, 2024 Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $400K 4 Jan 3, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Dec 16, 2022 2 $0 4 Dec 20, 2022 Director
LJPC LA JOLLA PHARMACEUTICAL CO Aug 22, 2022 11 -$74.8K 4 Aug 24, 2022 Director
LJPC LA JOLLA PHARMACEUTICAL CO Jul 8, 2022 2 $47.2K 4 Jul 12, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Director
LJPC LA JOLLA PHARMACEUTICAL CO Jan 12, 2022 1 $0 4 Jan 14, 2022 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Dec 21, 2021 3 -$2.43K 4 Dec 23, 2021 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Sep 21, 2021 1 -$3.07K 4 Sep 23, 2021 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jun 21, 2021 1 -$3.8K 4 Jun 22, 2021 Director